Pediatric covid-19 vaccines
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30123D16647
- Awardee
-
Moderna US, Inc. UEI G5BFKCJLDML6 Part of Modernatx, Inc.
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Pediatric COVID-19 Vaccines Solicitation · 75D30123R72709 · Posted Nov 16, 2022
- Last date to order 100% complete
- IDV ceiling
- $601,370,000.00
- Maximum order
- $386,595,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Centers for Disease Control and Prevention (CDC) has awarded a multiple award indefinite delivery indefinite quantity (IDIQ) contract for the purchase of standard commercial COVID-19 vaccines with a pediatric indication. The maximum ordering quantity is 30 million doses, with a minimum order of 100 doses. The vaccines procured will support pediatric immunization programs through the Vaccines for Children (VFC) and Section 317 vaccine purchase programs. The IDIQ has a ceiling value of $601,370,000 and a period of performance of one year from the date of award. Moderna US, Inc. is one of the prime contractors awarded this IDIQ contract. The contract provides an opportunity for the CDC to leverage VFC and Section 317 funds to obtain pediatric COVID-19 vaccines for distribution to state health departments and other eligible immunization awardees throughout the United States.
The original solicitation, which was set aside for manufacturers of pediatric vaccines, sought proposals for any number of COVID-19 vaccine brands that have received Emergency Use Authorization or Biologics License Approval from the FDA for use in children aged 0 through 18 years. The vaccines will be ordered through the CDC's Vaccine Tracking System and delivered to centralized distribution locations or directly to provider locations, depending on storage requirements. This IDIQ contract supports the CDC's efforts to ensure sufficient quantities of pediatric COVID-19 vaccines are available to meet national immunization program needs.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$148,664,506 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $309,512,081 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Original award | $17,182 |
Show all 11
Quick answers
Who was awarded contract 75D30123D16647?
75D30123D16647 was awarded to Moderna US, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on June 14, 2023.
How much is contract 75D30123D16647 worth?
75D30123D16647's own ceiling is $601,370,000. A single order can be worth up to $386,595,000.
Who can order from contract 75D30123D16647?
75D30123D16647 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30123D16647 competed?
The extent of competition for 75D30123D16647 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV